AR and prostate cancer: In summary, via demonstrating the role of USP14 in AR stabilization in androgen-responsive prostate cancer, here we provide a potentially new strategy for inhibiting AR-mediated prostate cancer carcinogenesis or progression through inhibition of USP14.